Apyx Medical Inc.
07/24/2026 | Press release | Distributed by Public on 07/24/2026 15:18
Material Event (Form 8-K)
| Item 8.01. | Other Events. |
On July 24, 2026, the Board of Directors (the "Board") of Apyx Medical Corporation (the "Company") reconstituted the membership and chairs of its standing committees as described below.
The membership and chairs of the reconstituted committees are as follows:
| 1. | Audit Committee: Lawrence J. Waldman (Chair), Minnie Baylor-Henry, and Wendy Levine; |
| 2. | Governance and Nominating Committee: Minnie Baylor-Henry (Chair), Lawrence J. Waldman, and Wendy Levine; |
| 3. | Regulatory Compliance Committee: Minnie Baylor-Henry (Chair), Lawrence J. Waldman, and Wendy Levine; and |
| 4. | Compensation Committee: Wendy Levine (Chair), Lawrence J. Waldman, and Minnie Baylor-Henry. |
In light of his appointment as Executive Chairman of the Board (effective June 11, 2026), Stavros Vizirgianakis will not serve on any committee of the Board.
The Board has determined that each of Mr. Waldman, Ms. Baylor-Henry, and Ms. Levine is "independent" under the applicable rules of The Nasdaq Global Select Market and the Securities and Exchange Commission. The Board has further determined that Mr. Waldman qualifies as an "audit committee financial expert" as defined by the rules and regulations of the Securities and Exchange Commission.
Apyx Medical Inc. published this content on July 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 24, 2026 at 21:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]